Tag: biopharma

Rimegepant is an orally disintegrating tablet (ODT) - a class of medications called calcitonin gene-related peptide (CGRP) receptor antagonist

The workshops, led by neurologists from KIMS and Yashoda Hospitals along with PRASHO’s public-health team, focus on early recognition, treatment, and workplace adaptation strategies

The Cover Story tracks how between 2015 and 2025, India’s healthcare and biotech firms transformed CSR from basic compliance to strategic, impact-driven initiatives. Also featuring interviews with: Merck Life Science’s Dhananjay Singh on strengthening India’s R&D and lab infrastructure. Maverick Simulation Solutions’ Anuj Chahal on investing Rs 50 crore in R&D, AI, and immersive learning.

The FDA released a new draft guidance proposing major changes to simplify biosimilarity studies and reduce unnecessary clinical testing

India climbs five places in global ranking, driven by growing R&D capacity and generics strength

The Enzene platform was one of four finalists selected by a panel of pharma industry experts.

The surge was driven by seven high value deals worth USD 2.6 billion, reflecting renewed investor confidence in scale and consolidation plays across pharma, biotech, and hospital segments

With a sharp focus on Good Manufacturing Practices (GMP), Quality Assurance, and Regulatory Affairs, the institute equips learners to navigate complex compliance environments and uphold international standards of safety and quality.

The facility has been designed with a range of advanced features to ensure both safety and efficiency

This milestone enables global procurement agencies such as UNICEF, Gavi, and PAHO to source Shanchol® for use in countries where cholera remains a major public health challenge